murine genital tract closely parallel those reported in and John A.McLachlan 4 humans (1-12). In fact, this DES-exposed animal model has both replicated and predicted lesions observed in similarly 1 Developmental Endocrinology Section, Reproductive Toxicology Group, exposed humans (13-15); however, the etiology of these binding to the estrogen receptor have been suggested to be important mechanisms in hormonal carcinogenesis (19). The Prenatal exposure to diethylstilbestrol (DES) is associated significance of these mechanisms is supported by our recent with reproductive tract abnormalities, subfertility and neostudy showing increased DES-induced tumor prevalence and plasia in experimental animals and humans. Studies using reduced time to tumor formation in the uteri of transgenic mice experimental animals suggest that the carcinogenic effects of DES may be transmitted to succeeding generations. To that overexpress the estrogen receptor (20). These findings are further evaluate this possibility and to determine if there consistent with other studies that suggest estrogens can be is a sensitive window of exposure, outbred CD-1 mice were epigenetic carcinogens, acting via a promoting effect related treated with DES during three developmental stages: group to cellular proliferation, mediated through the estrogen 1 was treated on days 9-16 of gestation (2.5, 5 or 10 µg/kg receptor (21-23). However, binding to the estrogen receptor maternal body weight) during major organogenesis; group and estrogenicity alone are not altogether sufficient to explain II was treated once on day 18 of gestation (1000 µg/kg the carcinogenic activity of estrogens because some estrogens maternal body weight) just prior to birth; and group III are not carcinogenic (24). was treated on days 1-5 of neonatal life (0.002 µg/pup/ Other mechanisms may be related to estrogen-induced day). DES-exposed female mice (F 1 ) were raised to maturity carcinogenesis (for review, see ref.
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25). While estrogens are and bred to control males to generate DES-lineage (F 2 )
not mutagenic in many assays, they do exhibit specific types descendants. The F 2 males obtained from these matings of genotoxic activity under certain conditions. In cell culture, are the subjects of this report; results in F 2 females DES, 17β-estradiol and their metabolites have been reported have been reported previously to induce morphological and neoplastic transformation of Carcinogenesis, 19, 1655-1663]. Reproductive performance Syrian hamster embryo (SHE) cells; SHE cells express no of F 2 males when bred to control females was not different measurable levels of estrogen receptor, and estrogen treatment from control males. However, in DES F 2 males killed at is not mitogenic to the cells (26). Thus, estrogenic activity 17-24 months, an increased incidence of proliferative apparently does not play a role in the transformation of these lesions of the rete testis and tumors of the reproductive cells. SHE cell transformation rates do, however, correlate tract was observed. Since these increases were seen in with aneuploidy induction and DNA damage caused by DNA all DES treatment groups, all exposure periods were adducts (25). Further evidence of genetic and epigenetic effects considered susceptible to perturbation by DES. These data associated with estrogen treatment has been described in our suggest that, while fertility of the DES F 2 mice appeared studies of developmentally DES-exposed mice (27,28) and unaltered, increased susceptibility for tumors is transmitted humans (29) , and in studies from other laboratories (30-32). from the DES 'grandmothers' to subsequent generations.
These data raise the possibility that the neoplastic changes seen following developmental exposure to DES may be related to epigenetic and/or genetic changes imprinted at the molecular Introduction level. Recent reviews lend support to this hypothesis (33, 34) . Whether these DES-induced changes persist and are transFor many years, research in our laboratory has centered on ferred to subsequent generations is not known, but growing studying the effects of diethylstilbestrol (DES) and other evidence in experimental animals suggests that this is indeed estrogens on differentiating reproductive tract tissues. Using a possibility; increased incidence of second generation tumors the CD-1 outbred mouse, we have shown that benign and has been reported (35-38). Although one study reported no adverse second generation effects of DES in a group of 8-12- (35) to be associated with pup/day; weight of pups ranged from 1 g on day 1 to 3.5 g on day 5), or corn multigenerational effects; and (iii) DES exposure on days oil alone (control), as described (9, 10) . From a pilot study which determined 1-5 of neonatal life, which we have previously reported to the fertility of female mice exposed neonatally to DES (unpublished data), result in an increased incidence of uterine adenocarcinoma in the dose of 0.002 µg/pup/day was chosen to generate a second generation for the F 1 generation (9,10), although the tumorigenic dose used this study, since the dose of 2 µg DES/pup/day used in our previous studies (9,10) was not compatible with fertility.
previously was 1000 times higher than that used in the current All mice were weaned at 3 weeks of age and housed five per cage until study. In the current study, we report that the increased further study. These mice are referred to as the descendants (F 2 ) as reported for the female descendants (40).
F 2 generation
The implications that DES and other estrogenic chemical According to a previously described protocol (4) 
Materials and methods
three groups were similar, they were averaged together and the data are F 0 generation presented as a single set. (In the course of the study, a larger number of females was determined to be necessary in group II, prenatal DES-day 18, so As described previously (3), adult CD-1 [Crl: CD-1 (ICR) BR] mice were that sufficient numbers of F 2 animals could be generated.) Females observed obtained from Charles River Breeding Laboratories (Raleigh, NC) and bred to be pregnant were removed and housed individually until delivery. When to male mice of the same line in the breeding facility at the National Institute F 1 female mice delivered their young, pups were counted and litters were of Environmental Health Sciences (NIEHS; Research Triangle Park, NC).
standardized to eight pups per litter whenever possible. The offspring of the Vaginal plug detection was considered day 0 of pregnancy. On day 9 of F 1 mice are referred to as second generation (F 2 ) or DES-lineage mice. All gestation, pregnant female mice were individually housed in cages with F 2 mice were weaned at 3 weeks of age and held four per cage for further hardwood chip bedding and a cotton fiber nesting block. Pregnant mice were study. The F 2 female littermates of the males described in this study have housed under controlled lighting (12 h light and 12 h dark) and controlled temperature (21-22°C) conditions. NIH-31 lab mouse chow and fresh water been reported separately (40). kidneys, adrenal glands and heart were also removed and similarly fixed. All unilateral testicular atrophy (testis weight ϭ 0.01 g).
tissues were processed, embedded in paraffin and sectioned at 6 µm. A Conversely, the left testis/body weight ratio was significantly standardized sectioning method was used for testes since the rete testis had previously been identified to be a target for DES-adverse effects (7, 14) . A (P Ͻ 0.05) elevated in the prenatal DES-10 group. However, mid-sagittal cut along the long axis of the testis through the hilus was made this was due entirely to the reduced body weight, since actual Serum testosterone and estrogen levels from the animals in (17-24 months) . Survival rates were similar between the two age groups.
the breeding study are plotted in Figure 2 . Although there is
Statistical analyses
a trend for testosterone levels to be lower in the DES F 2 males, Mann-Whitney U-tests (43) were used to compare body weights, reproductive tissue weights and serum hormone levels in DES and control groups. The none of the reductions was statistically significant, and any incidences of proliferative lesions (hyperplasia and tumors) were compared difference in these levels did not apparently affect fertility.
by Fisher's exact test (43) .
Serum estrogen levels were significantly (P Ͻ 0.05) reduced in the prenatal DES-2.5 group relative to controls ( Figure 2 ) Results but the biological importance is uncertain. Whether additional animals or younger animals show a similar trend needs further When 11-12-month-old DES-lineage (F 2 ) males were bred to examination. control females, few differences in fertility were observed
In contrast to the lack of a demonstrable affect on fertility, between the control and DES-treated groups. One male from DES-lineage (F 2 ) males clearly showed an increased incidence group I: prenatal DES-2.5, did not impregnate any females in proliferative lesions of the rete testis (hyperplasia and over the 12 week breeding period, even though housed with tumors) and reproductive tract tumors as compared with control multiple proven partners; all other F 2 DES males in the mice. Abnormalities observed in DES-lineage mice at 17-24 study were fertile. The average litter size (mean Ϯ SE) for months of age are summarized in Table II . the pregnant females was 11.4 Ϯ 0.4 control; group I, 10.3 Ϯ 0.5 prenatal DES-2.5, 10.0 Ϯ 0.7 prenatal DES-5, A normal rete testis from a control mouse is illustrated in Figure 3 . The irregular tubules of the rete are located at the demonstrate loss of polarity and nuclear atypia ( Figure 6B ). The combined incidence of proliferative lesions of the rete mediastinum of the testis. The channels of the rete are lined by cuboidal or flat epithelium. Rete testis hyperplasia (Figure testis (rete testis hyperplasia and tumors) summarized in Table III , suggests that the rete testis is a target for the 4) was seen in all F 2 groups but the incidence and degree of severity was more pronounced in the DES groups as compared transgenerational effects of DES. In this study, hyperplasia and tumors of the rete were summarized together because with controls. Furthermore, two tumors of the rete testis were seen in DES F 2 treated groups. In group I, prenatal DES-5, these lesions represented stages in the progression of rete disease based on prior information from DES-exposed male the rete tumor was composed of neoplastic cells that had focally penetrated through the basement membrane. The rete mice (7, 14) . Occurrence of other rare lesions in this area was was cystic, but the lining epithelial cells were not flattened ( Figure 5A and B) . The other rete testis tumor was in a group II, prenatal DES-day 18 animal ( Figure 6A) ; the lesion had both solid and papillary components composed of cells which Total testosterone (ng/ml) and total estradiol (pg/ml) levels measured in serum from DES-lineage (F 2 ) male mice killed at the end of the breeding study. *P Ͻ 0.05 versus controls (Mann-Whitney U-test). a F 1 female mice were exposed prenatally or neonatally to DES as described in Materials and methods. These DES F 1 females were mated with untreated control male mice to obtain the DES-lineage (F 2 ) males. The incidence of rete abnormalities was observed in the F 2 DES-lineage males (Figure 1) . b Relative to control (Fisher's exact test); NS, not significant. c One of these lesions was a rete testis tumor.
also observed. Tubuli recti hyperplasia in the testis (Figure 7 ) was seen in group I, prenatal DES-2.5. In this lesion, the terminal end of the seminiferous tubules was distended with an increased number of cells resembling those normally seen in this area. However, nuclear size variation and hyperchromatic nuclei were seen. Another rare lesion, found in the rete testis of a group II, prenatal DES-day 18 animal, was lipoid cell hyperplasia ( Figure 8 ). Cells with foamy cytoplasm were interspersed with the rete epithelial cells. There was extension of the foamy cells for a short distance into the efferent Interstitial cell hyperplasia and interstitial tumors were seen ants showed no corresponding increase (40). All other organs examined in this study showed no significant differences in incidence of tumors. in controls and all DES treatment groups; this finding is consistent with reports of these spontaneous occurring tumors Discussion in this mouse strain (44,45).
Other rare tumors in reproductive tract tissues were observed While the main focus of this study was to determine the incidence of proliferative lesions in DES-lineage male mice, in the DES-lineage (F 2 ) males. Of particular interest was a seminal vesicle papilloma [1/100 (1%)] and two seminal the fertility of a subset of these F 2 DES males was also examined at 11-12 months of age. Although one DES-lineage vesicle carcinosarcomas [2/100 (2%), Figure 9A Table II. finding in rodent breeding colonies. Of the fertile males in this study, no significant difference in reproductive outcome Sperm granulomas and inflammation in the epididymis were observed in all DES-lineage (F 2 ) groups.
between control and DES-lineage males was observed. Litter sizes were similar between control and all DES-lineage groups. The mammary gland was not routinely screened, but two animals in group II, prenatal DES-day 18 had lesions identified Sex ratios of the litters were not determined. Since a recent report described altered sex ratios in F 2 litters resulting from on gross examination; microscopic evaluation of these tumors showed pathological changes consistent with fibrosarcomas of the prenatal hormone environment of the mother (46) , this endpoint warrants further examination. Although variations in the milk line.
Other tissues were also screened for abnormalities. The body weights, reproductive tract tissue weights, and hormone levels were observed across groups, the differences did not incidence of hepatocellular neoplasms was not different between control and DES-lineage mice, but pulmonary neoresult in apparent altered reproductive outcomes. Additional DES-lineage animals need to be studied, however, to determine plasms occurred at approximately twice the rate [group I, prenatal DES-2.5 (37%), prenatal DES-5 (34%), prenatal if subtle effects on fertility exist, since infertility in laboratory animals may not be a sensitive endpoint in detecting an adverse DES-10 (21%); group II, prenatal DES-day 18 (38%); group III, neonatal DES (38%)] in DES-lineage (F 2 ) males as response to reproductive toxicants (47) . In contrast to the apparent lack of effects on fertility, compared with controls (12%). This finding is of uncertain and lipoid cell hyperplasia in group II, prenatal DES-day 18 mouse. Considering the changes in the intra-testicular duct system of the testis, reported in this study, this area appears to be a target for the transgenerational effects of DES with the distal portion of the ductuli recti and rete being particularly affected. Together, these DES-induced changes could have retrograde effects on the rest of the seminiferous tubule and further alter sperm transport resulting in sperm granulomas, which were also observed in DES-lineage males. A recent review summarized the toxic effects of several compounds including DES on the developing excurrent duct system (52); as pointed out, the rete testis and efferent ductules have received little attention in male reproductive toxicology in the past; therefore, it is difficult to know if these tissues are insensitive to toxicants or if they have been just overlooked. The transgenerational effects of DES described in this paper along with previous reports from this lab describing adverse effects including neoplasia of the rete testis following prenatal exposure to DES (7), suggest these tissues warrant additional study.
Other interesting findings in this study were the occurrence of rare tumors such as a seminal vesicle papilloma, two seminal vesicle carcinosarcomas, a seminal vesicle sarcoma and a prostatic neoplasm in DES-lineage mice.
The mechanisms involved in these transgenerational events are unknown. However, considering all the genetic/epigenetic effects (25,27-32,53) that have been associated with DES treatment, the possibility of germ cell alterations are feasible. In fact, one explanation for the transgenerational DES-effects of abnormal methylation patterns in estrogen-responsive genes in F 1 females following developmental DES exposure (28); whether this is related to DES-lineage carcinogenicity remains histological abnormalities in the genital tracts of the DESlineage mice (F 2 ) evaluated at 17-24 months of age suggested to be determined. However, changes in DNA methylation patterns are receiving renewed interest (55) (56) (57) . an increased incidence of tumors in the rete testis and reproductive tract tissues. While there is ample evidence that In summary, the data described in this report suggest that irreversible changes exist in developmentally DES-exposed exposure of pregnant females to DES and other chemicals results in tumors in their F 1 offspring (18, 48, 49) , the data in females that can be transmitted to their 'grandsons'. This concept is further strengthened by similar results in the F 2 this report add increasing support to the idea that exposure to some chemical carcinogens may result in increased female siblings in which, like the males (F 2 ) described in this study, reproduction is not apparently altered but cancers are incidences of tumors in more than one generation of 'untreated' descendants (50).
observed (40). The results obtained using this experimental animal model indicate that the cascade of events that lead to The transgenerational effects reported in this study are very interesting. As we have previously proposed for F 1 DESthe appearance of a tumor may well begin before birth and perhaps before conception. The data described in this report exposed males (7), the rete testis is a target for DES adverse effects; this observation has further support from a recent are further significant because this animal model can be used to study both genetic and epigenetic changes associated with study from another laboratory demonstrating adverse effects on the rete testis following exposure to a number of environmental developmental exposure to DES. Using this animal model, we can now systematically analyze and detect the changes caused estrogenic compounds (51) . In the current study, the highest rate of proliferative lesions in the rete testis was in group I, by DES, which will enable us to compare similarities and differences between mice and humans. The ability to detect prenatal DES-10 with 17/49 (35%) of the F 2 males having lesions at 17-24 months of age. Of particular significance, these genetic/epigenetic changes represents an important advancement in future cancer therapy and prevention. Furtherwas the occurrence of two rete tumors, one in group I, prenatal DES-5 [1/83 (1%)] and another in group II, prenatal DES-day more, this animal model permits us to reach across species and learn more about mechanisms involved in cancer, in 18 [1/52 (2%)]. Rete testis adenocarcinoma was reported previously by this laboratory in 5% of prenatally DES-exposed particular, the factors underlying the genetic predisposition to cancer. F 1 males (100 µg/kg maternal body weight) (7, 14) . Rete testis tumors are rare and were not observed in any control malesmeasurements in the serum samples. We also greatly appreciate the artistic 
